Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression
Digestive and Liver Disease · 2026-07 · 58 (7) · 957-965
DOI: 10.1016/j.dld.2026.04.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2026-07. Verfasst von E Catanzaro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Gastroenterology Unit, Azienda Ospedale-Università Padova,…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Fibric Acids, Fenofibrate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padua.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Gastroenterology Unit, Azienda Ospedale-Università Padova, Padova, Italy; ERN RARE-LIVER - European Reference Network on Rare He…
- Gastroenterology Unit, Azienda Ospedale-Università Padova, Padova, Italy; ERN RARE-LIVER - European Reference Network on Rare Hepatological Diseases.
- ERN RARE-LIVER - European Reference Network on Rare Hepatological Diseases; Gastroenterology and Digestive Endoscopy Unit, AULSS1 Dolomiti Veneto, Feltre, Belluno, Italy.
- Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
- Department of Internal Medicine, Mirano Hospital, ULSS 3 Serenissima, Mirano, Venice, Italy.
- Gastroenterology Unit, Azienda Ospedale-Università Padova, Padova, Italy; Multivisceral Transplant Unit, Azienda Ospedale - Università Padova, Padova, Italy.
Förderung
- University of Padua
Zitieren
APA
Catanzaro, E., Peviani, M., Bonaiuto, E., Pezzato, F., Benatti, M., Cavaliere, C., Perin, N., Russo, F. P., Gambato, M., Burra, P., Floreani, A., Motta, R., & Cazzagon, N. (2026). Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression. Digestive and Liver Disease, 58(7), 957-965. https://doi.org/10.1016/j.dld.2026.04.017
Vancouver
Catanzaro E, Peviani M, Bonaiuto E, Pezzato F, Benatti M, Cavaliere C, et al. Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression. Digestive and Liver Disease. 2026;58(7):957-965. doi:10.1016/j.dld.2026.04.017
BibTeX
@article{Catanzaro2026,
author = {Catanzaro, E and Peviani, M and Bonaiuto, E and Pezzato, F and Benatti, M and Cavaliere, C and Perin, N and Russo, F P and Gambato, M and Burra, P and Floreani, A and Motta, R and Cazzagon, N},
title = {Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression},
journal = {Digestive and Liver Disease},
year = {2026},
volume = {58},
number = {7},
pages = {957--965},
doi = {10.1016/j.dld.2026.04.017}
}
EUVIMED